Tevis Investment Management boosted its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 39.7% in the 1st quarter, HoldingsChannel reports. The firm owned 20,686 shares of the company’s stock after buying an additional 5,875 shares during the period. Procter & Gamble accounts for about 1.7% of Tevis Investment Management’s investment portfolio, making the stock its 15th largest holding. Tevis Investment Management’s holdings in Procter & Gamble were worth $2,988,000 as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Arbejdsmarkedets Tillaegspension raised its stake in shares of Procter & Gamble by 6.2% in the first quarter. Arbejdsmarkedets Tillaegspension now owns 176,981 shares of the company’s stock valued at $25,563,000 after acquiring an additional 10,405 shares during the last quarter. J. Safra Sarasin Holding AG grew its position in Procter & Gamble by 1.2% during the 1st quarter. J. Safra Sarasin Holding AG now owns 435,953 shares of the company’s stock worth $62,966,000 after acquiring an additional 5,209 shares during the last quarter. CORDA Investment Management LLC. grew its position in Procter & Gamble by 3.5% during the 1st quarter. CORDA Investment Management LLC. now owns 232,339 shares of the company’s stock worth $33,559,000 after acquiring an additional 7,847 shares during the last quarter. Brindle & Bay Financial Advisors LLC increased its holdings in Procter & Gamble by 4.2% during the 1st quarter. Brindle & Bay Financial Advisors LLC now owns 5,296 shares of the company’s stock valued at $765,000 after purchasing an additional 212 shares in the last quarter. Finally, Tradewinds LLC. raised its position in Procter & Gamble by 0.5% in the 1st quarter. Tradewinds LLC. now owns 24,502 shares of the company’s stock valued at $3,608,000 after purchasing an additional 131 shares during the last quarter. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Trading Up 0.1%
Shares of NYSE PG opened at $147.15 on Monday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The firm has a market capitalization of $342.65 billion, a P/E ratio of 21.51, a P/E/G ratio of 6.26 and a beta of 0.39. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53. The company’s 50 day simple moving average is $146.58 and its 200 day simple moving average is $148.41.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were issued a $1.0885 dividend. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. This represents a $4.35 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date was Friday, April 24th. Procter & Gamble’s dividend payout ratio is currently 63.60%.
Wall Street Analysts Forecast Growth
PG has been the topic of a number of recent analyst reports. Barclays reduced their price objective on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. The Goldman Sachs Group cut their price target on Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a report on Wednesday, April 8th. Rothschild & Co Redburn reduced their price target on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research report on Monday, April 27th. Jefferies Financial Group increased their price objective on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a report on Friday, June 26th. Finally, Morgan Stanley lowered their price objective on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Twelve analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $161.42.
Check Out Our Latest Analysis on Procter & Gamble
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: RBC Capital reportedly initiated/maintained a Buy rating on Procter & Gamble, reinforcing confidence in the company’s defensive earnings profile and dividend stability.
- Positive Sentiment: Bank of America kept a Buy rating on PG while lowering its price target to $166 from $170, still implying meaningful upside from current levels.
- Positive Sentiment: Recent commentary highlighted PG as a Dividend King with a long history of dividend growth, plus product launches such as Braun NEVO and Cascade Clean and Dry Booster Rinse Aid that could support brand momentum.
- Neutral Sentiment: Several market recap pieces noted that PG had recently underperformed the broader market in prior sessions, reflecting some near-term pressure rather than a company-specific shock.
- Neutral Sentiment: Other articles focused broadly on dividend investing strategies and retirement income ideas, using PG as an example of a reliable income stock rather than citing a new business catalyst.
- Negative Sentiment: One article framed PG as facing a “fresh market test,” suggesting investors are still assessing whether its valuation and growth outlook justify renewed buying.
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
